BMS inks deal with AI Proteins; Terns’ early-stage leukemia data

Plus, news about IPOs in Hong Kong, In­ven­tis­Bio and Al­li­ga­tor Bio­science:

Bris­tol My­ers Squibb part­ners with AI Pro­teins: The deal will

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.